doi: 10.1186/s12933-021-01400-9 Guo XH (2016): The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide
[DOI] [PMC free article] [PubMed] [Google Scholar] 62.Xu X.R., Zou Z.Y., Xiao X., Huang Y.M., Wang X., Lin X.M
AstraZeneca emphasizes cardiovascular and metabolic disease expertise with a focus on comprehensive therapeutic solutions and clinical excellence
On top of that, exercise on its own can improve cardiovascular and bone health, so its never an either-or decision, Kushner says
The role of adjunctive exenatide therapy in pediatric type 1 diabetes
This is one of the reasons these medications are associated with high rate of nausea and even vomiting. Patients who are on these medications have higher rate of excessive food residual in their stomachs despite going through the usual fasting period prior to procedures or surgeries, Rezaie explained